These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1469 related articles for article (PubMed ID: 34076901)

  • 1. Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study.
    Abd-Elsalam S; Noor RA; Badawi R; Khalaf M; Esmail ES; Soliman S; Abd El Ghafar MS; Elbahnasawy M; Moustafa EF; Hassany SM; Medhat MA; Ramadan HK; Eldeen MAS; Alboraie M; Cordie A; Esmat G
    J Med Virol; 2021 Oct; 93(10):5833-5838. PubMed ID: 34076901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
    Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Medina MF; Achinelli F; Guglielmone HA; Ojeda J; Farizano Salazar D; Andino G; Kawerin P; Dellamea S; Aquino AC; Flores V; Martemucci CN; Martinez SM; Segovia JE; Reynoso PI; Sosa NC; Robledo ME; Guarrochena JM; Vernengo MM; Ruiz Diaz N; Meza E; Aguirre MG
    BMC Infect Dis; 2021 Jul; 21(1):635. PubMed ID: 34215210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ivermectin for treatment of non-hospitalized COVID-19 patients: A systematic review and meta-analysis of 12 randomized controlled trials with 7,035 participants.
    Hernandez AV; Liu A; Roman YM; Burela PA; Pasupuleti V; Thota P; Carranza-Tamayo CO; Retamozo-Palacios M; Benites-Zapata VA; Piscoya A; Vidal JE
    Int J Antimicrob Agents; 2024 Aug; 64(2):107248. PubMed ID: 38908535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial.
    Wijewickrema A; Banneheke H; Pathmeswaran A; Refai FW; Kauranaratne M; Malavige N; Jeewandara C; Ekanayake M; Samaraweera D; Thambavita D; Galappatthy P
    BMC Infect Dis; 2024 Jul; 24(1):719. PubMed ID: 39039459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of Ivermectin in COVID-19 patients: A prospective study at a safety-net hospital.
    Ozer M; Goksu SY; Conception R; Ulker E; Balderas RM; Mahdi M; Manning Z; To K; Effendi M; Anandakrishnan R; Whitman M; Gugnani M
    J Med Virol; 2022 Apr; 94(4):1473-1480. PubMed ID: 34811753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial.
    Lim SCL; Hor CP; Tay KH; Mat Jelani A; Tan WH; Ker HB; Chow TS; Zaid M; Cheah WK; Lim HH; Khalid KE; Cheng JT; Mohd Unit H; An N; Nasruddin AB; Low LL; Khoo SWR; Loh JH; Zaidan NZ; Ab Wahab S; Song LH; Koh HM; King TL; Lai NM; Chidambaram SK; Peariasamy KM;
    JAMA Intern Med; 2022 Apr; 182(4):426-435. PubMed ID: 35179551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
    Rajter JC; Sherman MS; Fatteh N; Vogel F; Sacks J; Rajter JJ
    Chest; 2021 Jan; 159(1):85-92. PubMed ID: 33065103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.
    Samaha AA; Mouawia H; Fawaz M; Hassan H; Salami A; Bazzal AA; Saab HB; Al-Wakeel M; Alsaabi A; Chouman M; Moussawi MA; Ayoub H; Raad A; Hajjeh O; Eid AH; Raad H
    Viruses; 2021 May; 13(6):. PubMed ID: 34073401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.
    Aref ZF; Bazeed SEES; Hassan MH; Hassan AS; Rashad A; Hassan RG; Abdelmaksoud AA
    Int J Nanomedicine; 2021; 16():4063-4072. PubMed ID: 34163159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
    Okumuş N; Demirtürk N; Çetinkaya RA; Güner R; Avcı İY; Orhan S; Konya P; Şaylan B; Karalezli A; Yamanel L; Kayaaslan B; Yılmaz G; Savaşçı Ü; Eser F; Taşkın G
    BMC Infect Dis; 2021 May; 21(1):411. PubMed ID: 33947344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.